Insider digest · LLY
Eli Lilly insider filings, Oct 20, 2026
Eli Lilly insiders filed 4 routine Form 4 reports on Oct 20, 2026: awards. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.
What the codes mean: how to read a Form 4 · stock-based compensation.
Stock awards and grants
Shares or units the company granted as pay. No shares were bought or sold in the market. Total for the day: 35 shares or units, worth about $43,208 at the prices reported.
| Person | Code | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Ralph Alvarez · director | A | Common Stock | 10.011 | $1,240.34 | $12,417 | 55,848 |
| J. Erik Fyrwald · director | A | Common Stock | 7.995 | $1,240.34 | $9,917 | 75,544 |
| Juan R. Luciano · director | A | Common Stock | 12.832 | $1,240.34 | $15,917 | 16,970 |
| Gabrielle Sulzberger · director | A | Common Stock | 3.998 | $1,240.34 | $4,958 | 3,016 |
The filings
- Eli Lilly director Ralph Alvarez reports an award of about 10 shares · SEC filing index
- Eli Lilly director J. Erik Fyrwald reports an award of about 8 shares · SEC filing index
- Eli Lilly director Juan R. Luciano reports an award of about 13 shares · SEC filing index
- Eli Lilly director Gabrielle Sulzberger reports an award of about 4 shares · SEC filing index
Eli Lilly company file → · All Eli Lilly filings notes
Disclosures
- Editor holdings in LLY
- The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
- Compensation
- Nobody paid for this page. No affiliate links.
A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.